{"assertionCriteria": {"method": "ClinGen PAH ACMG Specifications v1", "citation": {"url": "https://submit.ncbi.nlm.nih.gov/ft/byid/i2ra5ppm/clingen_pah_acmg_specifications_v1.pdf"}}, "clinicalSignificance": {"citation": [{"url": "https://erepo.clinicalgenome.org/evrepo/ui/interpretation/93378ff3-a0f5-476d-9386-3bbd7a51e0f0"}], "clinicalSignificanceDescription": "Likely pathogenic", "comment": "This c.563G>T (p.Gly188Val) variant in PAH was reported in trans with pathogenic variant p.Val399= in 1 patient with PAH deficiency (>120 \u03bcmol/L Phe) (PMID: 28982351). Computational evidence for this missense variant is predicted to be damaging (SIFT), probably damaging (PolyPhen2), and disease-causing (MutationTaster). This variant is absent from population databases gnomAD, 1000 Genomes, and ESP. In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PM3, PP3, PP4.", "dateLastEvaluated": "2020-11-16", "modeOfInheritance": "Autosomal recessive inheritance"}, "conditionSet": {"condition": [{"db": "MONDO", "id": "MONDO:0009861"}]}, "localID": "93378ff3-a0f5-476d-9386-3bbd7a51e0f0", "localKey": "93378ff3-a0f5-476d-9386-3bbd7a51e0f0", "observedIn": [{"collectionMethod": "curation", "alleleOrigin": "germline", "affectedStatus": "unknown", "numberOfIndividuals": 0}], "recordStatus": "novel", "releaseStatus": "public", "variantSet": {"variant": [{"gene": [{"symbol": "PAH"}], "hgvs": "NC_000012.12:g.102855279C>A"}]}}